Romosozumab ‘safe and effective’ in women with osteoporosis and CKD
A post-hoc analysis shows the biologic reduced fracture risk with similar adverse event rates across a range of renal function levels.
Tag: Endocrinology – Osteoporosis
Risedronate ‘poses higher risk of fracture’ than alendronate during drug holiday
Patients may require closer monitoring two years after pausing treatment, researchers say.
Garvan Institute’s fracture risk tool ‘outperforms BMD’
The predictive performance of the calculator has been elucidated in a large overseas registry study.
TGA approves first biologic for heritable rickets
Some children with X-linked hypophosphataemia are being treated under the Special Access Scheme as the sponsor seeks PBS listing.
New guidance for BMD surveillance in youth post-cancer
An expert panel has evaluated the circumstances demanding surveillance and how it should be conducted.
Bone development ‘abnormal’ in teens with type 1 diabetes
Routine assessment of BMD should be considered in this patient population, paediatric endocrinologists suggest.
Cognitive decline ups fracture risk in older women, study shows
Although no causal link has been established, researchers say findings highlight the importance of monitoring cognitive function and bone loss in t…
Long-term bisphosphonate in breast cancer ‘provides no extra benefit’
It may be time to question the role of the bone-sparing therapy, say expert commentators.
Erythropoietin therapy tied to hip-fracture risk in patients on dialysis
For patients on a high dose it appears to be on a par with other well-known risk factors, authors say.
Uric acid levels tied to hip fracture risk: study
Researchers think serum levels might be useful biomarker in older patients.
